Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device

American Journal of Cardiology

Volumn 112, Issue 9, 2013, Pages 1403-1409

  Sohail, M Rizwan ^a   Henrikson, Charles A ^b   Braid Forbes, Mary Jo ^c   Forbes, Kevin F ^d   Lerner, Daniel J ^e  

^a Mayo Clinic College of Medicine   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Braid Forbes Health Research   (United States)

^d CATHOLIC UNIVERSITY OF AMERICA   (United States)

^e Tyrx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR IMPLANTABLE ELECTRONIC; COHORT ANALYSIS; DEATH; DEVICE INFECTION; DISEASE ASSOCIATION; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LENGTH OF STAY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICARE; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; ODDS RATIO; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84885947512     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.06.031     Document Type: Article

References (17)

1. K.G. Tarakji, E.J. Chan, D.J. Cantillon, A.L. Doonan, T. Hu, S. Schmitt, T.G. Fraser, A. Kim, S.M. Gordon, and B.L. Wilkoff Cardiac implantable electronic device infections: presentation, management, and patient outcomes Heart Rhythm 7 2010 1043 1047
2. M.R. Sohail, C.A. Henrikson, M.J. Braid-Forbes, K.F. Forbes, and D.J. Lerner Mortality and cost associated with cardiovascular implantable electronic device infections Arch Intern Med 171 2011 1821 1828
3. M.R. Sohail, D.Z. Uslan, A.H. Khan, P.A. Friedman, D.L. Hayes, W.R. Wilson, J.M. Steckelberg, S. Stoner, and L.M. Baddour Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections J Am Coll Cardiol 49 2007 1851 1859
4. L.M. Baddour, A.E. Epstein, C.C. Erickson, B.P. Knight, M.E. Levison, P.B. Lockhart, F.A. Masoudi, E.J. Okum, W.R. Wilson, L.B. Beerman, A.F. Bolger, N.A.M. Estes III, M. Gewitz, J.W. Newburger, E.B. Schron, K.A. Taubert the American Heart Association Rheumatic Fever E, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Y, Council on Cardiovascular S, Anesthesia, Council on Cardiovascular N, Council on Clinical C, the Interdisciplinary Council on Quality of C, Outcomes R Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation 121 2010 458 477
5. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27
6. D.A. Southern, H. Quan, and W.A. Ghali Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data Med Care 42 2004 355 360
7. B. Li, D. Evans, P. Faris, S. Dean, and H. Quan Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases BMC Health Serv Res 8 2008 12
8. (HCUP) AfHRaQAHCaUP Comorbidity Software: Healthcare Cost and Utilization Project (HCUP) 2011
9. D. Collett Modelling Binary Data 2003 Chapman & Hall/CRC Boca Raton 387p
10. J. Hilbe Negative Binomial Regression 2007 Cambridge University Press Cambridge; New York xii, 251 p
11. T.S. Baman, S.K. Gupta, J.A. Valle, and E. Yamada Risk factors for mortality in patients with cardiac device-related infection Circ Arrhythm Electrophysiol 2 2009 129 134
12. R. Margey, H. McCann, G. Blake, E. Keelan, J. Galvin, M. Lynch, N. Mahon, D. Sugrue, and J. O'Neill Contemporary management of and outcomes from cardiac device related infections Europace 12 2010 64 70
13. A. Voigt, A. Shalaby, and S. Saba Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights Pacing Clin Electrophysiol 33 2010 414 419
14. J.Z. Ayanian, and A.M. Epstein Differences in the use of procedures between women and men hospitalized for coronary heart disease N Engl J Med 325 1991 221 225
15. V. Vaccarino, S.S. Rathore, N.K. Wenger, P.D. Frederick, J.L. Abramson, H.V. Barron, A. Manhapra, S. Mallik, and H.M. Krumholz Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002 N Engl J Med 353 2005 671 682
16. P.N. Peterson, S.L. Daugherty, Y. Wang, H.J. Vidaillet, P.A. Heidenreich, J.P. Curtis, and F.A. Masoudi Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy Circulation 119 2009 1078 1084
17. H.L. Bloom, L.D. Constantin, D.L. Daniel, B. David, M. El-Chami, L.I. Ganz, K.J. Gleed, F.K. Hackett, N.K. Kanuru, D.J. Lerner, A.S. Rasekh, R.S. Grant, O. Felix, M.R. Sohail, and for the COMMAND (COoperative Multicenter study Monitoring a CIED ANtimicrobial Device) Investigators Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial Envelope Pacing Clin Electrophysiol 34 2011 133 142